Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study
Background: Treating chronic urticaria (CU) that is unresponsive to H1-antihistamines (H1AHs) is challenging, and the real-world effectiveness of omalizumab remains unclear. Objective: Our aim was to evaluate the real-world effectiveness of omalizumab, optimal response assessment timing, and predict...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-05-01
|
| Serier: | Journal of Allergy and Clinical Immunology: Global |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2772829324000419 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
